Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.63 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1504319 | 0.98 | CYP19A1 (0.61) | CYP19A1PTPN11PTPN1NPC1ALDH1A1 | |
| SCHEMBL21568080 | 0.88 | NPC1 (0.67) | NPC1ALDH1A1TSHRKMT2AMEN1 | |
| SCHEMBL10495628 | 0.88 | PTPN11 (0.74) | CYP19A1PTPN11PTPN1GPR35KMT2A | |
| Lithium Ion SCHEMBL1504314 | 0.83 | NPC1 (0.55) | CYP19A1NPC1ALDH1A1TSHRKMT2A | |
| SCHEMBL1507740 | 0.81 | NPC1 (0.64) | NPC1ALDH1A1TSHRKMT2AMEN1 | |
| SCHEMBL5433635 | 0.80 | ALDH1A1 (0.59) | CYP19A1NPC1ALDH1A1TSHRKMT2A | |
| SCHEMBL672629 | 0.80 | NPC1 (0.69) | NPC1ALDH1A1TSHRKMT2AMEN1 | |
| SCHEMBL6394183 | 0.79 | ALDH1A1 (0.63) | CYP19A1PTPN11PTPN1ALDH1A1GPR35 | |
| SCHEMBL9378918 | 0.78 | ALDH1A1 (0.68) | NPC1ALDH1A1TSHRKMT2AMEN1 | |
| SCHEMBL10718716 | 0.78 | NPC1 (0.55) | NPC1ALDH1A1TSHRKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119948005-A | Method for synthesizing methoxy substituted benzaldehyde compound | 先正达农作物保护股份公司 | 2025-05-06 | — | — | CN | claimed |
| EP-4608796-A1 | PROCESS FOR THE SYNTHESIS OF METHOXY SUBSTITUTED BENZALDEHYDE COMPOUNDS | Syngenta Crop Protection AG (CH) | 2025-09-03 | — | — | EP | disclosed |
| CN-119948005-A | Method for synthesizing methoxy substituted benzaldehyde compound | 先正达农作物保护股份公司 | 2025-05-06 | — | — | CN | disclosed |
| WO-2024089225-A1 | PROCESS FOR THE SYNTHESIS OF METHOXY SUBSTITUTED BENZALDEHYDE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2024-05-02 | — | — | WO | disclosed |
| CN-115403519-B | Synthesis method of N-substituted isonicotinamide compound driven by visible light | 河南师范大学 | 2024-03-01 | — | — | CN | disclosed |
| CN-115385858-B | Photocatalytic preparation method of 2-phenyl-2H-indazole-3-carboxamide compound | 河南师范大学 | 2024-03-01 | — | — | CN | disclosed |
| CN-114728917-B | Oxamide derivative, preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-114728917-A | Oxamide derivative, preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| WO-2021110076-A1 | OXAMIDE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE | 深圳信立泰药业股份有限公司 | 2021-06-10 | — | — | WO | disclosed |
| US-20200352931-A1 | OXALAMIDES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE | Phenex Discovery Verwaltungs-GmbH (DE) | 2020-11-12 | — | — | US | disclosed |
| CN-1745071-A | Novel ethylenediamine derivative | DAIICHI SEIYAKU CO (JP) | 2006-03-08 | — | — | CN | disclosed |
| US-20050245565-A1 | Diamine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-11-03 | — | — | US | disclosed |
| EP-1577301-A1 | DIAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-09-21 | — | — | EP | disclosed |
| EP-1577302-A1 | NOVEL ETHYLENEDIAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-09-21 | — | — | EP | disclosed |
| US-20050119486-A1 | Diamine derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2005-06-02 | — | — | US | disclosed |
| US-20050020645-A1 | Diamine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-01-27 | — | — | US | disclosed |
| EP-1415992-A1 | DIAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-05-06 | — | — | EP | disclosed |
| EP-1405852-A1 | DIAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-04-07 | — | — | EP | disclosed |
| EP-0086746-B1 | PHENYLAMINO-OXO-ACETIC ACIDS AND THEIR ESTERS AS HERBICIDAL ANTIDOTES FOR THE PROTECTION OF CULTIVATED PLANTS | CIBA-GEIGY AG (CH) | 1986-07-30 | — | — | EP | disclosed |
| US-4191840-A | Oxamic acid derivatives | AMERICAN HOME PRODUCTS CORPORATION (US) | 1980-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200352931-A1 | OXALAMIDES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE | IDO1, IDO2, INMT | CYP19A1 626/4885PTPN11 1995/4885PTPN1 1172/4885 |
| US-20050020645-A1 | Diamine derivatives | C9, C1S, C1R | CYP19A1 3110/4885PTPN11 4663/4885PTPN1 4702/4885 |
| US-20050245565-A1 | Diamine derivatives | C9, C1S, C1R | CYP19A1 3110/4885PTPN11 4663/4885PTPN1 4702/4885 |
| US-20050119486-A1 | Diamine derivatives | C9, C1S, C1R | CYP19A1 3110/4885PTPN11 4663/4885PTPN1 4702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.